These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 25860130)

  • 1. Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis.
    Matsunaga S; Kishi T; Iwata N
    PLoS One; 2015; 10(4):e0123289. PubMed ID: 25860130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Memantine for dementia.
    Areosa SA; Sherriff F
    Cochrane Database Syst Rev; 2003; (1):CD003154. PubMed ID: 12535459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of discontinuation, efficacy, and safety of memantine treatment for Alzheimer's disease: meta-analysis and meta-regression of 18 randomized clinical trials involving 5004 patients.
    Blanco-Silvente L; Capellà D; Garre-Olmo J; Vilalta-Franch J; Castells X
    BMC Geriatr; 2018 Jul; 18(1):168. PubMed ID: 30041625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with cholinesterase inhibitors and memantine for Alzheimer's disease: a systematic review and meta-analysis.
    Matsunaga S; Kishi T; Iwata N
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25548104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis.
    Kishi T; Matsunaga S; Oya K; Nomura I; Ikuta T; Iwata N
    J Alzheimers Dis; 2017; 60(2):401-425. PubMed ID: 28922160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P
    Drugs Aging; 2019 May; 36(5):435-452. PubMed ID: 30937879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease.
    Schmidt R; Hofer E; Bouwman FH; Buerger K; Cordonnier C; Fladby T; Galimberti D; Georges J; Heneka MT; Hort J; Laczó J; Molinuevo JL; O'Brien JT; Religa D; Scheltens P; Schott JM; Sorbi S
    Eur J Neurol; 2015 Jun; 22(6):889-98. PubMed ID: 25808982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of memantine for the treatment of Alzheimer's disease.
    Matsunaga S; Kishi T; Nomura I; Sakuma K; Okuya M; Ikuta T; Iwata N
    Expert Opin Drug Saf; 2018 Oct; 17(10):1053-1061. PubMed ID: 30222469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis.
    Glinz D; Gloy VL; Monsch AU; Kressig RW; Patel C; McCord KA; Ademi Z; Tomonaga Y; Schwenkglenks M; Bucher HC; Raatz H
    Swiss Med Wkly; 2019 Jun; 149():w20093. PubMed ID: 31269225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time to Treatment Initiation in People With Alzheimer Disease: A Meta-Analysis of Randomized Controlled Trials.
    Tsoi KK; Hirai HW; Chan JY; Kwok TC
    J Am Med Dir Assoc; 2016 Jan; 17(1):24-30. PubMed ID: 26392193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination Therapy Showed Limited Superiority Over Monotherapy for Alzheimer Disease: A Meta-analysis of 14 Randomized Trials.
    Tsoi KK; Chan JY; Leung NW; Hirai HW; Wong SY; Kwok TC
    J Am Med Dir Assoc; 2016 Sep; 17(9):863.e1-8. PubMed ID: 27349622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The place of memantine in the treatment of Alzheimer's disease: a number needed to treat analysis.
    Livingston G; Katona C
    Int J Geriatr Psychiatry; 2004 Oct; 19(10):919-25. PubMed ID: 15449303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.
    Tan CC; Yu JT; Wang HF; Tan MS; Meng XF; Wang C; Jiang T; Zhu XC; Tan L
    J Alzheimers Dis; 2014; 41(2):615-31. PubMed ID: 24662102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memantine treatment for Japanese patients with moderate to severe Alzheimer's disease: a meta-analysis of double-blind, randomized, placebo-controlled trials.
    Kishi T; Matsunaga S; Iwata N
    Neuropsychiatr Dis Treat; 2018; 14():2915-2922. PubMed ID: 30464475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials.
    Kavirajan H; Schneider LS
    Lancet Neurol; 2007 Sep; 6(9):782-92. PubMed ID: 17689146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monotherapy Is Good Enough for Patients with Mild-to-Moderate Alzheimer's Disease: A Network Meta-analysis of 76 Randomized Controlled Trials.
    Tsoi KK; Chan JY; Chan FC; Hirai HW; Kwok TC; Wong SY
    Clin Pharmacol Ther; 2019 Jan; 105(1):121-130. PubMed ID: 29717478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memantine for Lewy body disorders: systematic review and meta-analysis.
    Matsunaga S; Kishi T; Iwata N
    Am J Geriatr Psychiatry; 2015 Apr; 23(4):373-383. PubMed ID: 24406251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
    Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
    J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials.
    Matsunaga S; Kishi T; Iwata N
    J Alzheimers Dis; 2016 Sep; 54(2):635-43. PubMed ID: 27497482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NMDA receptor antagonists interventions in schizophrenia: Meta-analysis of randomized, placebo-controlled trials.
    Kishi T; Iwata N
    J Psychiatr Res; 2013 Sep; 47(9):1143-9. PubMed ID: 23692933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.